Immuno-oncology focus: questions to be answered
How can we continue the success of checkpoint inhibitors for bladder cancer treatment?
Urothelial carcinoma treatment: the future
The difficulties in treating squamous cell lung cancer
The challenges of using biomarkers for immunotherapy
R. Donald Harvey